1-8 of 8
Julian Adams
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Transcriptional and Metabolic Profiling of Nicotinamide-Enhanced Natural Killer (NAM-NK) Cells (GDA-201)

Free
Dima Yackoubov, Aviad Pato, Julia Rifman, Sherri Cohen, Astar Hailu, Nurit Persi, Orit Berhani-Zipori, Avishai Edri, Boaz Buhandler, Moshe Shahor, Nathan Dinowitz, Amram Ben David, Avi Izraeli, Vered Caspi, Liron Levin, Amnon Peled, Frank Cichocki, Joshua Rabinowitz, Wenyun Lu, Melanie McReynolds, Tracey Lodie, Julian Adams, Ronit Simantov, Yona Geffen
Journal: Blood
Blood (2021) 138 (Supplement 1): 4791.
https://doi.org/10.1182/blood-2021-149468
Published: 2021
Journal Articles

Nicotinamide (NAM) Modulates Transcriptional Signature of Ex Vivo Cultured UCB CD34+ Cells (Omidubicel) and Preserves Their Stemness and Engraftment Potential

Free
Tracey Lodie, PhD, Julian Adams, PhD, Dima Yackoubov, Msc, Yair Steinhardt, MSc, Dorit Ashengrau, Adi Bitansky, Alina Maliutina, Sherry Cohen, Boaz Buhenvald, PhD, Moshe Shahor, PhD, Nathan Dinowitz, PhD, Vered Caspi, PhD, Amnon Peled, PhD, Tony Peled, MSc
Journal: Blood
Blood (2019) 134 (Supplement_1): 3718.
https://doi.org/10.1182/blood-2019-131124
Published: 2019
Journal Articles

Investigation of a Novel Cyclin-Dependent-Kinase (CDK) Inhibitor Cdki-73 As an Effective Treatment Option for MLL-AML

Free
Ka Leung Li, BSc (Hons), Sarah C Bray, PhD, Diana Iarossi, BSc (Hons), Julian Adams, PhD, Longjin Zhong, Ben Noll, BSc (Hons), Muhammed H Rahaman, BSc (Hons), Jennifer Richmond, BSc(Hons), Luen Bik To, MBBS, PhD, Ian D Lewis, MBBS, PhD FRACP, FRCPA, Richard B Lock, PhD, Shudong Wang, PhD, Richard J D'Andrea, PhD
Journal: Blood
Blood (2015) 126 (23): 1365.
https://doi.org/10.1182/blood.V126.23.1365.1365
Published: 2015
Journal Articles

Update on Phase I Clinical Trial of IPI-504, a Novel, Water-Soluble Hsp90 Inhibitor, in Patients with Relapsed/Refractory Multiple Myeloma (MM).

Free
David Siegel, MD, PhD, Sundar Jagannath, MD, Amitabha Mazumder, MD, David Vesole, MD, Ivan Borrello, MD, Jens Sydor, PhD, Jim Wright, PhD, Jon Patterson, BS, Emmanuel Normant, PhD, Julian Adams, PhD, Kenneth Anderson, MD, David Grayzel, MD, Paul Richardson, MD
Journal: Blood
Blood (2006) 108 (11): 3579.
https://doi.org/10.1182/blood.V108.11.3579.3579
Published: 2006
Journal Articles

Phase I Clinical Trial of IPI-504, a Novel, Water-Soluble Hsp90 Inhibitor, in Patients with Relapsed/Refractory Multiple Myeloma (MM).

Free
Sundar Jagannath, MD, David Siegel, MD, Paul Richardson, MD, Amitabha Mazumder, MD, Jens Sydor, PhD, Jill Goddard, John Walker, Jon Patterson, Emmanuel Normant, PhD, Jeffrey Tong, PhD, Vito Palombella, PhD, Ken Anderson, MD, Julian Adams, PhD, David Grayzel, MD
Journal: Blood
Blood (2005) 106 (11): 2560.
https://doi.org/10.1182/blood.V106.11.2560.2560
Published: 2005
Journal Articles

Phase 1 trial of the proteasome inhibitor bortezomib and pegylated liposomal doxorubicin in patients with advanced hematologic malignancies

Free
Clinical Trials & Observations
Robert Z. Orlowski, Peter M. Voorhees, Reynaldo A. Garcia, Melissa D. Hall, Fred J. Kudrik, Tammy Allred, Anandhi R. Johri, Paul E. Jones, Anastasia Ivanova, Hendrik W. Van Deventer, Don A. Gabriel, Thomas C. Shea, Beverly S. Mitchell, Julian Adams, Dixie-Lee Esseltine, Elizabeth G. Trehu, Marie Green, Mary Jo Lehman, Susan Natoli, Jason M. Collins, Celeste M. Lindley, E. Claire Dees
Journal: Blood
Blood (2005) 105 (8): 3058–3065.
https://doi.org/10.1182/blood-2004-07-2911
Published: 2005
Journal Articles

IPI-504: A Novel hsp90 Inhibitor with In Vitro and In Vivo Anti-Tumor Activity.

Free
Constantine S. Mitsiades, MD, PhD, Nicholas Mitsiades, MD, PhD, Melissa Rooney, Joseph Negri, Corey C. Geer, MSc, Melissa Pink, Christine Pien, Teru Hideshima, MD, PhD, Dharminder Chauhan, PhD, Nikhil C. Munshi, MD, PhD, Paul G. Richardson, MD, John Barrett, PhD, Jeffrey K. Tong, PhD, David Grayzel, Vito Palombella, PhD, Julian Adams, PhD, Kenneth C. Anderson, MD
Journal: Blood
Blood (2004) 104 (11): 2403.
https://doi.org/10.1182/blood.V104.11.2403.2403
Published: 2004
Journal Articles

Anti-Tumor Activity of IPI-504, a Novel Hsp90 Inhibitor in Multiple Myeloma.

Free
Vito J. Palombella, Ph.D., Emmanuel Normant, Ph.D., Janid Ali, Ph.D., John Barrett, Ph.D., Michael Foley, Ph.D., Yun Gao, Ph.D., Jennie Ge, Ph.D., Asimina T. Georges, Ph.D., David Grayzel, M.D., Louis Grenier, Jebecka Hudak, Roger Pak, Ph.D., Jon Patterson, Christine Pien, Melissa Pink, James Porter, Ph.D., Junbiao Sang, Kerry Spear, Ph.D., Jens Sydor, Ph.D., Jim Wright, Ph.D., Constantine S. Mitsiades, M.D., Kenneth C. Anderson, M.D., Julian Adams, Ph.D., Jeffrey Tong, Ph.D.
Journal: Blood
Blood (2004) 104 (11): 4922.
https://doi.org/10.1182/blood.V104.11.4922.4922
Published: 2004